Cargando…

Questioning the justification for a fourth SARS-CoV-2 vaccine

Detalles Bibliográficos
Autores principales:	Calderon-Margalit, Ronit, Strahilevitz, Jacob, Paltiel, Ora
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940721/ https://www.ncbi.nlm.nih.gov/pubmed/35339674 http://dx.doi.org/10.1016/j.cmi.2022.03.023

Ejemplares similares

SARS-CoV-2 and human reproduction: An open question
por: Entezami, Frida, et al.
Publicado: (2020)

The epidemiology and pathogenesis of SARS-CoV-2 infection in pregnancy: More questions than answers
por: Odayar, Jasantha, et al.
Publicado: (2020)

Timely development of vaccines against SARS-CoV-2
por: Lu, Shan
Publicado: (2020)

Inactivated SARS-CoV-2 vaccine for people with HIV
por: Wolday, Dawit, et al.
Publicado: (2022)

Is there a post-SARS-CoV-2 vaccination dementia?
por: Fiorini, Ana C., et al.
Publicado: (2022)

In search of justification for the unpredictability paradox
por: Howick, Jeremy, et al.
Publicado: (2014)

Unanticipated efficacy of SARS-CoV-2 vaccination in older adults
por: Pawelec, Graham, et al.
Publicado: (2021)

Multicomponent vaccines to fight SARS-CoV-2 variants of concern
por: Cassone, Antonio, et al.
Publicado: (2021)

The challenge of emerging SARS-CoV-2 mutants to vaccine development
por: Li, Rong, et al.
Publicado: (2021)

SARS-CoV-2 immunogenicity: Is S protein the best target for vaccination?
por: Antonopoulou, Tania, et al.
Publicado: (2022)

SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
por: Salvatori, Giovanni, et al.
Publicado: (2020)

Pregnant people deserve the protection offered by SARS-CoV-2 vaccines
por: Maykin, Melanie M., et al.
Publicado: (2021)

Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
por: Hajissa, Khalid, et al.
Publicado: (2021)

COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants
por: Cevik, Muge, et al.
Publicado: (2021)

SARS-CoV-2 vaccination for immune-comprised patients: More is required
por: Li, Hui, et al.
Publicado: (2021)

Socioeconomic disparities in breast cancer incidence and survival among parous women: findings from a population-based cohort, 1964–2008
por: Goldberg, Mandy, et al.
Publicado: (2015)

Entropy as the main justification for research in medical ethics
por: Zarzavadjian Le Bian, Alban, et al.
Publicado: (2022)

Are Healthcare Workers Infected with SARS-CoV-2 at Home or at Work? A Comparative Prevalence Study
por: Zahran, Shadi, et al.
Publicado: (2022)

Trends in the performance of quality indicators for diabetes care in the community and in diabetes-related health status: an Israeli ecological study
por: Calderon-Margalit, Ronit, et al.
Publicado: (2018)

Skin rashes after SARS‐CoV‐2 vaccine: which relationship, if any?
por: Patruno, Cataldo, et al.
Publicado: (2021)

Vaccine against SARS-CoV-2 in previously infected health care workers
por: Parisi, Saverio Giuseppe
Publicado: (2021)

Increasing SARS-CoV-2 vaccination rates among Black people in Canada
por: Eissa, Azza, et al.
Publicado: (2021)

Consulting the Oracle of SARS-CoV-2 Infection
por: Lemieux, Jacob E, et al.
Publicado: (2021)

Pathogenicity of SARS‐CoV‐2 Omicron
por: Chu, Hin, et al.
Publicado: (2022)

Antigenic imprinting in SARS‐CoV‐2
por: Reincke, S. Momsen, et al.
Publicado: (2022)

SARS-CoV-2 Vaccination and the Bridge between First and Fourth Dose: Where Are We?
por: Stasi, Cristina, et al.
Publicado: (2022)

Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not?
por: Keikha, Masoud
Publicado: (2022)

Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not?
por: Keikha, Masoud
Publicado: (2022)

Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose
por: Bladh, Oscar, et al.
Publicado: (2023)

Duration of quarantine in hospitalized patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: a question needing an answer
por: Lombardi, A., et al.
Publicado: (2020)

Still Unanswered Questions about SARS-CoV-2 Mortality and Future Directions for Occupational Medicine
por: Zocchetti, Carlo, et al.
Publicado: (2023)

SARS-CoV-2 vaccination in the context of original antigenic sin
por: Petráš, Marek, et al.
Publicado: (2021)

Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development
por: Cohen, Samuel A., et al.
Publicado: (2020)

The potential risks of delaying the second vaccine dose during the SARS-CoV-2 pandemic
por: Humphreys, I R, et al.
Publicado: (2021)

Why we may need to rethink future SARS-CoV-2 vaccination strategies
por: Klimek, Peter
Publicado: (2021)

Validation of the effectiveness of SARS-CoV-2 vaccines in older adults in “real-world” settings
por: Weng, Nan-ping, et al.
Publicado: (2021)

The role of observational studies based on secondary data in studying SARS-CoV-2 vaccines
por: Barda, Noam, et al.
Publicado: (2022)

Experimental studies using OMV in a new platform of SARS-CoV-2 vaccines
por: Gaspar, Emanuelle B., et al.
Publicado: (2021)

Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines
por: Kelso, John M.
Publicado: (2021)

Platelet size as a mirror for the immune response after SARS‐CoV‐2 vaccination
por: Thiele, Thomas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tp1gets2ai8ilmrne6vspd530m